Document Detail


Prostatic acid phosphatase, a neglected ectonucleotidase.
MedLine Citation:
PMID:  19322680     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Two recent papers reveal that the soluble and secreted prostatic acid phosphatase, an enzyme that has long served as a diagnostic marker for prostate cancer, has a membrane-bound splice variant. This enzyme exhibits ecto-5'-nucleotidase activity, is widely distributed, and implicated in the formation of chronic pain. While prostatic acid phosphatase hydrolyzes phosphomonoesters other than 5'-nucleoside monophosphates these novel data suggest that, in addition to ecto-5'-nucleotidase and the alkaline phosphatases, prostatic acid phosphatase must be taken into account in future studies on extracellular adenosine production.
Authors:
Herbert Zimmermann
Publication Detail:
Type:  Journal Article     Date:  2009-03-26
Journal Detail:
Title:  Purinergic signalling     Volume:  5     ISSN:  1573-9538     ISO Abbreviation:  Purinergic Signal.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-07-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101250499     Medline TA:  Purinergic Signal     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  273-5     Citation Subset:  -    
Affiliation:
Institute of Cell Biology and Neuroscience, Biocenter, Goethe-University, 60438, Frankfurt, Germany, h.zimmermann@bio.uni-frankurt.de.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Distribution profiles of transient receptor potential melastatin- and vanilloid-related channels in ...
Next Document:  Progesterone reduces depression-like behavior in a murine model of Alzheimer's Disease.